Patient-centric clinical trials represent a transformative approach in the realm of medical research, placing the needs and perspectives of patients at the forefront. Emphasizing collaboration and engagement, these trials aim to enhance the overall patient experience, ensuring their voices are heard in the development and execution of research protocols. In patient-centric trials, there is a conscious effort to streamline participation processes, reducing burdens on patients while maximizing the collection of meaningful data. Transparent communication, simplified consent procedures, and accessible trial information contribute to fostering a sense of empowerment and understanding among participants.
The integration of patient input in study design and endpoint selection contributes to the relevance and effectiveness of clinical trials. Patient-centricity extends beyond data collection to encompass the overall well-being of participants, recognizing their unique needs and challenges throughout the trial journey. Patient-centric clinical trials embody a paradigm shift, aligning with the principles of personalized medicine and recognizing the individuality of each patient. As this approach gains prominence, it not only promotes greater patient satisfaction but also contributes to more robust and applicable research outcomes.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico